Management and board

Olof Sköld, CEO
Olof is one of the founders of Denator and is today CEO in the company. His entrepreneurial career started in 1999 when he founded the advertising company XeniacDesign. Olof holds a M.Sc in Electronics from Uppsala and M.Sc Innovation and Entrepreneurship from Chalmers University of Technology.

Wenche Rolfsen, Chairman
Wenche has held several top positions within the Pharmaceutical Industry, mainly at Pharmacia Upjohn and as the CEO for Quintiles Scandinavia for many years. Wenche is an Uppsala University graduate with a PhD in Pharmacology and holds an adjunct professorship at the same university.
Other present chairmanships: Aprea AB
Present board memberships: Biovitrum AB, Industrifonden, Artimplant AB and Aker Biomarine AS (Norway)

Henrik Wingstrand
Henrik is CEO of the venture capital company T-bolaget AB.

Martin Nicklasson
Martin's professional experience and career development spans over 30 years in the pharmaceutical industry. He has held key senior executive positions such as President and CEO of Astra Zeneca and Biovitrum. Most recently, he served as the CEO of Swedish Orphan Biovitrum AB.

Present board memberships: Swedish Heart & Lung Foundation, Stockholm Chamber of Commerce, Scandinavian Life Science Invest AB and Biocrine AB.

Nils Kristensen
Mr. Kristensen began his professional career with Ericsson in 1991 as a process engineer. He has held several senior management positions in production and development at Ericsson Microelectronics and Ericsson Radio Systems both in the US and Sweden. He is currently Vice President Operations at Gyros.

Dr. Karl Sköld
Karl is one of the founders of Denator. He encountered the problems with degradation during his research at Uppsala University. This research was the starting point of the company.